A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety, tolerability, pharmacokinetics
and pharmacodynamics of multiple ascending doses of PF-05175157 in healthy volunteers and
patients with type 2 diabetes mellitus.